Chemotherapy for malignant pleural mesothelioma: past results and recent developments von TOMEK, S, EMRI, S, KREJCY, K, MANEGOLD, C

Volltext

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES von Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva‐Kyuchukova, L., Egyed, M., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Empson, V., Krejcy, K., Hasselbalch, H., Kralovics, R., Kiladjian, J.‐J.

Volltext

Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin : A multicenter phase II trial von MANEGOLD, C, GATZEMEIER, U, VON PAWEL, J, PIRKER, R, MALAYERI, R, BLATTER, J, KREJCY, K

Volltext

Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients von Baselga, J., Llombart-Cussac, A., Bellet, M., Guillem-Porta, V., Enas, N., Krejcy, K., Carrasco, E., Kayitalire, L., Kuta, M., Lluch, A., Vodvarka, P., Kerbrat, P., Namer, M., Petruzelka, L.

Volltext

A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma von Kose, M.F., Sufliarsky, J., Beslija, S., Saip, P., Tulunay, G., Krejcy, K., Minarik, T., Fitzthum, E., Hayden, A., Melemed, A.

Volltext

Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine von Wolzt, M, Schmetterer, L, Ferber, W, Artner, E, Mensik, C, Eichler, H. G, Krejcy, K

Volltext

Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC) von Belani, C. P., Brodowicz, T., Ciuleanu, T., Kim, J. H., Krzakowski, M., Laack, E., Wu, Y. L., Peterson, P., Krejcy, K., Zielinski, C.

Volltext

PS1457 MAINTENANCE OF RESPONSE IN LONG‐TERM TREATMENT WITH ROPEGINTERFERON ALFA‐2B (BESREMI®) VS. HYDROXYUREA IN POLYCYTHEMIA VERA PATIENTS (PROUD/CONTINUATION‐PV PHASE III TRIALS)... von Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva‐Kyuchukova, L., Egyed, M., Rossiev, V., Dulicek, P., illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K., Grohmann‐Izay, B., Maurer, G., Hasselbalch, H.C., Kralovics, R., Kiladjian, J.‐J.

Volltext

Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study von Zatloukal, P, Kanitz, E, Magyar, P, Jassem, J, Krzakowski, M, Pawlicki, M, Petruzelka, L, Chovan, L, Pesek, M, Janko, C, Krejcy, K

Volltext

Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC) von Belani, C. P., Brodowicz, T., Ciuleanu, T., Kim, J. H., Krzakowski, M., Laack, E., Wu, Y. L., Peterson, P., Krejcy, K., Zielinski, C.

Volltext

Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC) von Belani, C. P., Brodowicz, T., Ciuleanu, T., Kim, J. H., Krzakowski, M., Laack, E., Wu, Y. L., Peterson, P., Krejcy, K., Zielinski, C.

Volltext

Smoking and prognostic factors in advanced non-small cell lung cancer (NSCLC) von Altug, S., Li, C., Marek, M., Guclu, S., Kim, Y., Meshref, M., Qin, S., Krejcy, K., Reece, W.

Volltext

Smoking and prognostic factors in an observational setting in patients with advanced non-small cell lung carcinoma (NSCLC; B9E-AA-B004) von Altug, S., Li, C., Marek, M., Güçlü, S. Z., Kim, Y., Meshref, M. M., Qin, S., Krejcy, K., Reece, W. H.

Volltext

Gemcitabine in non-small cell lung cancer (NSCLC) von MANEGOLD, C, ZATLOUKAL, P, KREJCY, K, BLATTER, J

Volltext

A phase II study of pemetrexed plus carboplatin as first-line therapy of patients with locally advanced (LA) or metastatic breast cancer (MBC): Preliminary results von Garin, A., Manikhas, A., Biakhov, M., Chezhin, M., Ivanchenko, T., Krejcy, K., Karaseva, V., Tjuyandin, S.

Volltext

Antiarrhythmic efficacy of labetalol as assessed by programmed electrical stimulation von Krumpl, G., Todt, H., Krejcy, K., Raberger, G.

Volltext

Mechanism of Antiarrhythmic Efficacy of Propafenone as Assessed by Programmed Electrical Stimulation in Conscious Dogs von Todt, H, Krumpl, G, Krejcy, K, Raberger, G

Volltext

Sex differences in concentrations of exhaled nitric oxide and plasma nitrate von Jilma, Bernd, Kastner, Johannes, Mensik, Christa, Vondrovec, Barbara, Hildebrandt, Jörg, Krejcy, kurt, Wagner, Oswald F, Eichler, Hans-georg

Volltext

Dose-ranging study of N G -nitro-L-arginine pharmacokinetics in rats after bolus intravenous administration von Piotrovskij, V., Kallay, Z., Horecky, J., Trnovec, T., Krumpl, G., Krejcy, K.

Volltext

Dose-ranging study of NG-nitro-L-arginine pharmacokinetics in rats after bolus intravenous administration von Piotrovskij, V., Kallay, Z., Horecky, J., Trnovec, T., Krumpl, G., Krejcy, K.

Volltext